南昌市那里医治躁狂症(南昌医治疗医院精神病) (今日更新中)

BEIJING, Nov. 17 (Xinhua) -- The Beijing municipal government Thursday launched a news release platform on Sina's weibo.com, China's popular Twitter-like microblogging service.Twenty municipal government agencies will post newly-unveiled policies and regulations, work developments, and information of news conferences on the joint microblog account, said Wang Hui, head of the Beijing municipal government's information office.The government departments will also timely answer hot topics and social concerns, Wang said.Many government departments have their own microblog accounts. The municipal public security bureau, for example, opened its microblog in August last year and now has over 1.8 million followers."I'm happy I can communicate directly with the government. And I hope my viewpoints and suggestions can get attention," said weibo user 1910060523.Many, however, question the move. "Is it really the case that everything can be said here and the government will read the comments and give responses?" said another user.Wang Hui said, "We are not just making a show. We shall be sincere to answer public's concerns over hot topics."

WASHINGTON, Nov. 14 (Xinhua) -- Nearly a fifth of all Americans 12 years or older have hearing loss so severe that it may make communication difficult, according to a new study led by Johns Hopkins University researchers and published Monday in the Archives of Internal Medicine.The findings, thought to be the first nationally representative estimate of hearing loss, suggest that many more people than previously thought are affected by this condition.Study leader Frank Lin, an assistant professor, and his colleagues used data from the National Health and Nutritional Examination Surveys (NHANES), a research program that has periodically gathered health data from thousands of Americans since 1971. The researchers analyzed data from all participants age 12 and over whose hearing was tested during NHANES examinations from 2001 to 2008. Unlike previous estimates, NHANES includes men and women of all races and ages, from cities scattered across the country, so it's thought to statistically mimic the population of the Untied States.Using the World Health Organization's definition for hearing loss (not being able to hear sounds of 25 decibels or less in the speech frequencies), the researchers found that overall, about 30 million Americans, or 12.7 percent of the population, had hearing loss in both ears. That number jumps to about 48 million, or 20.3 percent, for people who have hearing loss in at least one ear. These numbers far surpass previous estimates of 21 to 29 million.Hearing loss prevalence nearly doubled with every age decade, with women and blacks being significantly less likely to have hearing loss at any age. Lin and his colleagues aren't sure why these groups appear to be protected. However, he notes that the female hormone estrogen, as well as the melanin pigment in darker skin, could have a protective effect on the inner ear.

BEIJING,Nov. 9 (Xinhuanet) – Yinghuo-1, China's first interplanetary spacecraft, is set to hitch a ride with Russia's Phobos-Grunt Mars mission in the early hours on Wednesday, after a two-year delay.A Zenit-2SB rocket will carry Yinghuo-1 and Phobos-Grunt into space from the Baikonur Cosmodrome launch site in Kazakhstan.It is China and Russia's first joint Mars operation and also marks China's first voyage to the Red Planet, China Great Wall Industry Corp said in a news release on Tuesday.Yinghuo-1 will work in orbit with Phobos-Grunt for more than 12 months in collecting data on the Martian atmosphere.Both spacecraft will travel for more than 10 months before entering Martian orbit. During the trip, Yinghuo-1's power supply, communications and temperature gauge will be controlled from the Russian craft, scientists said.Both craft will orbit the planet three times before decoupling. The 106-kg Yinghuo-1 will circle Mars in an elliptical orbit, while Phobos-Grunt will actually land on Phobos, one of the two Martian moons, and bring back soil samples to Earth."The collaboration with Russia will enhance China's ability in deep space exploration, improve spacecraft design and development, and promote planetary exploration," said an unnamed official with the corp, a subsidiary of the China Aerospace Science & Technology Corp. Russia's Lavochkin Research and Production Association signed a cooperation contract, based on an agreement between the Chinese and Russian governments, with China Great Wall Industry Corp in 2007.Yinghuo-1, with a two-year lifespan, also has its own scientific goals.These include analyzing the planet's magnetic environment and ionosphere (upper atmosphere), taking images of topographical features and studying gravity fields on the Martian equator.Pang Zhihao, deputy editor-in-chief of the monthly publication, Space International, said China's focus on the planet's upper atmosphere is significant.Twenty detectors have explored parts of Mars, but most of them have looked for traces of life or water or places suitable for setting up colonies, he said.But studying the upper atmosphere is also vital if humans are to live on the planet, he said.The mission was set for October 2009, but later postponed to this year to enhance the reliability of the project.Only the United States, the former Soviet Union and the European Union have succeeded in landing probes on Mars. Five are in operation, four belong to the US and one belongs to the EU.At least 21 probes sent to the planet have failed. The Shanghai Academy of Spaceflight Technology under the CASC, which designed Yinghuo-1 in 23 months, said that the satellite posed a major technological challenge as the furthest space destination for China before had been the moon. The moon's average distance from Earth is about 384,000 km. The distance between Mars and Earth, depending on orbits, ranges from approximately 55 million km to about 350 million km.Yinghuo-1 will have to endure periods in the freezing dark side of the planet.It underwent simulated tests that matched the Martian temperature, - 260 C.Because of the distances involved, the satellite cannot rely on ground control to adjust position. It will rely on its own onboard computer, scientists said.

BEIJING, Oct. 27 (Xinhuanet) -- A new study shows that it's not simply a lack of willpower that explains weight regain but hormones keep one insisting on eating, a persistent biological urge. As any dieter knows, it's hard to keep weight off. Weight regain is a familiar problem for dieters. The research appears in Thursday's issue of the New England Journal of Medicine. To study what drives it, Proietto and his colleagues enrolled 50 overweight or obese patients in Australia in a 10-week diet program. On average, the participants lost almost 30 pounds in the 10 weeks - faster than the standard advice of losing a pound or two per week. Even so, they gained an average of 12 pounds back over the next year. The scientists checked the blood levels of nine hormones known to influence appetite - and found that even a year after the end of the weight-loss program, six of the hormones were still out of whack. People who regain weight should not be harsh on themselves, as eating is our most basic instinct, study author Joseph Proietto of the University of Melbourne in Australia said. It's better not to gain weight than to try to lose it.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday revoked its approval of Avastin for treating the breast cancer after concluding that the drug has not been shown to be safe and effective for that use.Avastin will still remain on the market as an approved treatment for certain types of colon, lung, kidney and brain cancer."After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," FDA Commissioner Margaret Hamburg said in a statement. "Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life. "Avastin's risks include severe high blood pressure; bleeding and hemorrhaging; heart attack or heart failure; and the development of perforations in different parts of the body such as the nose, stomach, and intestines.Avastin was approved for metastatic breast cancer in February 2008 under the FDA's accelerated approval program, which allows a drug to be approved based on data that are not sufficiently complete to permit full approval. After the approval, the drug's sponsor, Genentech, completed two additional clinical trials and submitted the data from those studies to the FDA. These data showed only a small effect on tumor growth without evidence that patients lived any longer or had a better quality of life compared to taking standard chemotherapy alone -- not enough to outweigh the risk of taking the drug.FDA's Center for Drug Evaluation and Research, which is responsible for the approval of this drug, ultimately concluded that the results of these additional studies did not justify continued approval and notified Genentech it was proposing to withdraw approval of the indication.Genentech did not agree with the Center's evaluation of the data and, following the procedures set out in FDA regulations, requested a hearing on the Center's withdrawal proposal, with a decision to be made by the Commissioner. That two-day hearing, which took place June 28-29, included recommendations from the FDA 's Oncologic Drugs Advisory Committee, voting 6-0 in favor of withdrawing approval of Avastin's breast cancer indication.

来源：资阳报